NCT04713774

Brief Summary

The investigators project is based on:

  • Assessment of bone architecture by high resolution peripheral scanner (HRpQCT) and bone densitometry (DEXA);
  • The non-invasive detection of vascular calcifications (by abdominal CT scanner) and bone abnormalities associated with kidney transplantation, as well as the analysis of evolution over time;
  • Longitudinal evaluation of nephrological clinical parameters (glomerular filtration rate, number and type of rejections, immunosuppressive medications) as well as biological and urinary parameters of mineral metabolism (parathormone, sclerostin, bone alkaline phosphatase) depending on the type and severity of bone abnormalities;
  • The evaluation of these nephrological clinical parameters and of the biological parameters of mineral metabolism depending on the extent and evolution of vascular calcifications but also on bone morphology;
  • The study of possible relationships between bone mass and muscle mass (and functioning)

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
7mo left

Started Sep 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Sep 2020Dec 2026

Study Start

First participant enrolled

September 1, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 8, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 19, 2021

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2026

Expected
Last Updated

December 18, 2024

Status Verified

December 1, 2024

Enrollment Period

5.3 years

First QC Date

January 8, 2021

Last Update Submit

December 13, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Bone density evolution

    Evolution of bone density after kidney transplantation

    At 1 year

  • Bone density evolution

    Evolution of bone density after kidney transplantation

    At 2 year

  • Bone micro-architecture evolution

    Bone micro-architecture evolution evaluate by HRpQCT after kidney transplantation

    At 1 year

  • Bone micro-architecture evolution

    Bone micro-architecture evolution evaluate by HRpQCT after kidney transplantation

    At 2 year

Secondary Outcomes (2)

  • Vascular calcification evolution

    At 1 year

  • Vascular calcification evolution

    At 3 months, 1 year and 2 years

Interventions

HR-pQCT images of the distal radius and distal tibia (non-dominant, non-fractured limb) will be obtained using the XtremeCT device with standard protocols. HR-pQCT images wil be analysed with standard software and extended cortical measures software. This software identifies the periosteal and endosteal boundaries, enabling assessment of cortical micro- structural bone properties, including apparent cortical thickness (Ct.Th, mm), cortical tissue mineral density (TMD, mgHA/cm3) and cortical porosity (Ct.Po, %).

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Kidney recipients aged over 18 and of all sexes recruited from the Centre Hospitalier Universitaire de Liege

You may qualify if:

  • At least 18 years old
  • Recent kidney transplant patients (\<3 months)
  • Medical history available
  • Biological parameters of the past year available

You may not qualify if:

  • Treatment with bisphosphonate, RANKL inhibitor or SERM with bone action in the last 3 months before the transplant
  • Multiple organ transplant patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire de Liège

Liège, 4300, Belgium

RECRUITING

MeSH Terms

Conditions

Bone Diseases, Metabolic

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Antoine Bouquegneau

    University of Liege

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pierre Delanaye

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 8, 2021

First Posted

January 19, 2021

Study Start

September 1, 2020

Primary Completion

December 12, 2025

Study Completion (Estimated)

December 13, 2026

Last Updated

December 18, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations